Maeike Zijlmans1,2, Gregory A Worrell3, Matthias Dümpelmann4, Thomas Stieglitz5, Andrei Barborica6, Marcel Heers4,7,8, Akio Ikeda9, Naotaka Usui10, Michel Le Van Quyen11. 1. Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, The Netherlands. 3. Mayo Systems Electrophysiology Laboratory, Departments of Neurology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, U.S.A. 4. Epilepsy Center, Medical Center - Faculty of Medicine, University of Freiburg, Freiburg, Germany. 5. Laboratory for Biomedical Microtechnology, Department of Microsystems Engineering-IMTEK and BrainLinks-BrainTools Cluster of Excellence, University of Freiburg, Freiburg, Germany. 6. Physics Department, University of Bucharest, Magurele, Romania. 7. Brainlinks-Braintools, Cluster of Excellence, University of Freiburg, Freiburg, Germany. 8. Ruhr-Epileptology/Department of Neurology, University Hospital Bochum, Bochum, Germany. 9. Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, Kyoto, Japan. 10. National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan. 11. Institute for Brain and Spinal Cord, Pitié-Salpêtrière University Hospital, Paris, France.
Abstract
OBJECTIVE: Technology for localizing epileptogenic brain regions plays a central role in surgical planning. Recent improvements in acquisition and electrode technology have revealed that high-frequency oscillations (HFOs) within the 80-500 Hz frequency range provide the neurophysiologist with new information about the extent of the epileptogenic tissue in addition to ictal and interictal lower frequency events. Nevertheless, two decades after their discovery there remain questions about HFOs as biomarkers of epileptogenic brain and there use in clinical practice. METHODS: In this review, we provide practical, technical guidance for epileptologists and clinical researchers on recording, evaluation, and interpretation of ripples, fast ripples, and very high-frequency oscillations. RESULTS: We emphasize the importance of low noise recording to minimize artifacts. HFO analysis, either visual or with automatic detection methods, of high fidelity recordings can still be challenging because of various artifacts including muscle, movement, and filtering. Magnetoencephalography and intracranial electroencephalography (iEEG) recordings are subject to the same artifacts. SIGNIFICANCE: High-frequency oscillations are promising new biomarkers in epilepsy. This review provides interested researchers and clinicians with a review of current state of the art of recording and identification and potential challenges to clinical translation. Wiley Periodicals, Inc.
OBJECTIVE: Technology for localizing epileptogenic brain regions plays a central role in surgical planning. Recent improvements in acquisition and electrode technology have revealed that high-frequency oscillations (HFOs) within the 80-500 Hz frequency range provide the neurophysiologist with new information about the extent of the epileptogenic tissue in addition to ictal and interictal lower frequency events. Nevertheless, two decades after their discovery there remain questions about HFOs as biomarkers of epileptogenic brain and there use in clinical practice. METHODS: In this review, we provide practical, technical guidance for epileptologists and clinical researchers on recording, evaluation, and interpretation of ripples, fast ripples, and very high-frequency oscillations. RESULTS: We emphasize the importance of low noise recording to minimize artifacts. HFO analysis, either visual or with automatic detection methods, of high fidelity recordings can still be challenging because of various artifacts including muscle, movement, and filtering. Magnetoencephalography and intracranial electroencephalography (iEEG) recordings are subject to the same artifacts. SIGNIFICANCE: High-frequency oscillations are promising new biomarkers in epilepsy. This review provides interested researchers and clinicians with a review of current state of the art of recording and identification and potential challenges to clinical translation. Wiley Periodicals, Inc.
Authors: Johannes B Erhardt; Thomas Lottner; Jessica Martinez; Ali C Özen; Martin Schuettler; Thomas Stieglitz; Daniel B Ennis; Michael Bock Journal: Neuroimage Date: 2019-03-29 Impact factor: 6.556
Authors: Somin Lee; Naoum P Issa; Sandra Rose; James X Tao; Peter C Warnke; Vernon L Towle; Wim van Drongelen; Shasha Wu Journal: Seizure Date: 2019-05-03 Impact factor: 3.184
Authors: Shennan A Weiss; Zachary Waldman; Federico Raimondo; Diego Slezak; Mustafa Donmez; Gregory Worrell; Anatol Bragin; Jerome Engel; Richard Staba; Michael Sperling Journal: Biomark Med Date: 2019-05-02 Impact factor: 2.851
Authors: Birgit Frauscher; Fabrice Bartolomei; Katsuhiro Kobayashi; Jan Cimbalnik; Maryse A van 't Klooster; Stefan Rampp; Hiroshi Otsubo; Yvonne Höller; Joyce Y Wu; Eishi Asano; Jerome Engel; Philippe Kahane; Julia Jacobs; Jean Gotman Journal: Epilepsia Date: 2017-06-30 Impact factor: 5.864
Authors: Anteneh M Feyissa; Gregory A Worrell; William O Tatum; Deependra Mahato; Benjamin H Brinkmann; Steven S Rosenfeld; Karim ReFaey; Perry S Bechtle; Alfredo Quinones-Hinojosa Journal: Neurology Date: 2018-02-28 Impact factor: 9.910
Authors: Aljoscha Thomschewski; Nathalie Gerner; Patrick B Langthaler; Eugen Trinka; Arne C Bathke; Jürgen Fell; Yvonne Höller Journal: Front Neurol Date: 2020-10-19 Impact factor: 4.003